Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de George Scangos
Age : 71
Public asset : 355,678,350 USD
Country of residence : Unknown
Linked companies : Agilent Technologies, Inc. - Vir Biotechnology, Inc.

Biography of George Scangos 
George A. Scangos is a businessperson who has been the head of 10 different companies and currently occupies the position of President, Chief Executive Officer & Director at Vir Biotechnology, Inc. He is also Member-National Board of Visitor at the University of California and on the board of 5 other companies. In his past career George A. Scangos held the position of Director at Decibel Therapeutics, Inc., Chief Executive Officer & Director at Biogen, Inc. Chief Executive Officer at Biogen Idec New Ventures, Inc. and Chief Executive Officer of Biogen Idec, Inc. (North Carolina) (both are subsidiaries of Biogen, Inc.), President, Chief Executive Officer & Director at Exelixis, Inc., President for Bayer Biotechnology, Chairman of Anadys Pharmaceuticals, Inc., Chairman of California Healthcare Institute, Senior Vice President-Research & Development at Bayer, Inc., President-Biotechnology Division at Bayer Corp., Chairman for Pharmaceutical Research & Manufacturers of America and Professor at The Johns Hopkins University. He received a doctorate from the University of Massachusetts and an undergraduate degree from Cornell University.


Current positions of George Scangos 
Holdings of George Scangos 
George Scangos : Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
RE
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
More news


© 2021 People and Ownership :   
George Scangos : Connections 


Latest news about George Scangos 
05/26GLAXOSMITHKLINE : GSK-Vir Sotrovimab Treatment for COVID-19 Gets Emergency Use Authorization in US
MT
05/26Covid-19 Treatment From Vir, GlaxoSmithKline Is Approved -- Update
DJ
05/21EU regulator backs use of GSK-Vir antibody to treat COVID-19
RE
03/10Covid-19 Antibody Drug Effective in Study, GlaxoSmithKline and Vir Say
DJ
03/10Vir, GSK to seek emergency use clearance for COVID-19 antibody therapy
RE
03/03VIR BIOTECHNOLOGY : Shares Down 29% After Update on NIH-Sponsored Trial
DJ
03/03VIR BIOTECHNOLOGY : GSK to halt enrollment in U.S. COVID-19 antibody trial sub-study
RE
More news